10 Best Stocks Under $10 That Could Triple
On July 2, Dominic Pappalardo, Chief Multi-Asset Strategist at Morningstar Wealth, shared his views on small-cap stocks, which are projected to sustain their above-market performance as valuations stay...
Verastem Inc. (VSTM)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Armistice Capital Steven Boyd | 7,024,000 | $26,831,680 | +53% | 0.33% |
| 2. | Deep Track Capital David Kroin | 5,740,850 | $21,930,047 | 0.32% | |
| 3. | Nantahala Capital Management Wilmot B. Harkey And Daniel Mack | 3,584,820 | $13,694,012 | 0.46% | |
| 4. | Stonepine Capital Timothy P. Lynch | 3,349,627 | $12,795,575 | +2% | 5.99% |
| 5. | Baker Bros. Advisors Julian Baker And Felix Baker | 2,499,338 | $9,547,471 | +328% | 0.05% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.84 | 2,000 | $7,680.00 | 2,000 | 2017-09-05 | Filing | |
| $2.17 | 50,000 | $108,500.00 | 218,000 | 2020-12-04 | Filing | |
| $3.21 | 33,000 | $105,930.00 | 168,000 | 2019-03-15 | Filing | |
| $7.31 | 5,000 | $36,550.00 | 135,000 | 2018-09-28 | Filing | |
| $7.30 | 3,000 | $21,900.00 | 10,700 | 2018-09-28 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $5.81 | 1,302 | $7,564.62 | 589,940 | 2026-08-03 | Filing | |
| $4.18 | 20,871 | $87,240.78 | 591,242 | 2026-06-22 | Filing | |
| $4.13 | 57 | $235.41 | 117,238 | 2026-06-22 | Filing | |
| $4.18 | 4,032 | $16,853.76 | 117,295 | 2026-06-22 | Filing | |
| $5.82 | 806 | $4,690.92 | 612,113 | 2026-05-04 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 9,192,447 | $35,115,146 | 0% | |
| 2. | 6,635,793 | $25,348,729 | 0.22% | |
| 3. | 5,133,859 | $19,611,341 | 0% | |
| 4. | 3,986,509 | $15,228,464 | 5.66% | |
| 5. | 3,851,508 | $14,712,761 | 0% |
News See All
9 Best Small-Cap Growth Stocks to Invest In Now
On June 30, CNBC released a research report noting that the US small-cap stocks are having the best first half since 1991.
10 Best Stocks Under $10 Offering More Than 50% Upside
Despite war-related risks to consumer spending and inflation, SCFR remains optimistic about the broader U.S. economy and the stock market.
Is Verastem, Inc. (VSTM)’s KRAS-Targeted Combination Therapy a Breakthrough for Pancreatic Cancer?
TheFly reported on June 17 that VSTM Oncology announced updated safety and efficacy findings from the RAMP 205 Phase 1b/2a Recommended Phase 2 Dose cohort.
10 Most Promising Small-Cap Stocks to Buy According to Hedge Funds
Tom Lee of Fundstrat spoke on CNBC's Closing Bell on June 9 about chip stocks, market mood, and the overall picture for stocks.
Verastem, Inc. (NASDAQ:VSTM) Q1 2026 Earnings Call Transcript
Operator: Good afternoon, and welcome to Verastem Oncology's First Quarter 2026 Earnings Conference Call. My name is Daniel, and I will be your call operator today.
Verastem, Inc. (NASDAQ:VSTM) Q4 2025 Earnings Call Transcript
Operator: Good afternoon, and welcome to Verastem Oncology's Fourth Quarter and Full Year 2025 Earnings Conference Call. My name is Desiree, and I will be your call operator today.
Verastem, Inc. (NASDAQ:VSTM) Q3 2025 Earnings Call Transcript
Operator: Good morning, and welcome to Verastem Oncology's Third Quarter 2025 Earnings Conference Call. My name is Liz, and I'll be your call operator for today.
Verastem, Inc. (VSTM) Delivers Positive Preliminary Data for VS-7375 in Mutant Solid Tumors Treatment
Verastem, Inc. (NASDAQ:VSTM) is one of the top long-term biotechnology stocks to buy. On October 23, Verastem, Inc.
Top 8 Long-Term Biotechnology Stocks to Buy
Momentum in biotechnology stocks is accelerating after years of underperformance.
Hedge Fund Resource Center